Amgen Inc (NASDAQ:AMGN) under-valued by 8%
Website | http://www.amgen.com |
Sector | Healthcare |
Industry | Drug Manufacturers General |
Fiscal Year End | Dec 31, 2021 |
Market Cap | $142,851,358,720 |
Beta | 0.735245 |
Average Volume | $2,810,847 |
Last Dividend | 6.72% |
Price on Feb 16, 2022 | $219.27 |
Autochartist™ Valuation | $237.17 |
Conclusion |
8% under-valued |
Download Report |